2006 annual financial data
Alnylam Pharmaceuticals 2006 Operating margin
Direct answer
Operating margin was -146.68%.
Operating income was -39,501,000 USD and net income was -34,608,000 USD.
Operating cash flow was -24,630,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,930,000 USD
- Operating income
- -39,501,000 USD
- Net income
- -34,608,000 USD
- Operating cash flow
- -24,630,000 USD